Información:
Error:
ID
21792
Descripción
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00254254
Link
https://clinicaltrials.gov/show/NCT00254254
Palabras clave
Versiones (1)
- 30/4/17 30/4/17 -
Subido en
30 de abril de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Type 2 Diabetes Mellitus NCT00254254
Eligibility Type 2 Diabetes Mellitus NCT00254254
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00254254
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Diabetes Treatment
Item
treatment with diet and exercise alone or a stable dose of metformin, or sulfonylurea, or metformin plus a sulfonylurea for at least 3 months.
boolean
C0087111 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
C0011849 (UMLS CUI [1,2])
HbA1c
Item
has hba1c 6.0% to 11.0%, inclusive, at screening.
boolean
C0019018 (UMLS CUI [1])
BMI
Item
has a body weight of >= 50 kg at screening.
boolean
C1305855 (UMLS CUI [1])
Experimental Drug and Study Participation Status
Item
received any investigational drug or has participated in any type of clinical trial within 3 months prior to screening.
boolean
C0304229 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C2348568 (UMLS CUI [2])
Study Participation Status
Item
currently participates in any other interventional study.
boolean
C2348568 (UMLS CUI [1])
Pharmacotherapy
Item
is currently treated with any of the following excluded medications:
boolean
C0013216 (UMLS CUI [1])
Sulfonylurea, chlorpropamide
Item
sulfonylurea chlorpropamide
boolean
C0038766 (UMLS CUI [1])
C0008287 (UMLS CUI [2])
C0008287 (UMLS CUI [2])
Thiazolidinedione
Item
thiazolidinedione within 3 months of screening.
boolean
C1257987 (UMLS CUI [1])
Alpha glucosidase inhibitor
Item
αlpha glucosidase inhibitor within 3 months of screening.
boolean
C3539108 (UMLS CUI [1])
Meglitinide
Item
meglitinide within 3 months of screening.
boolean
C0065880 (UMLS CUI [1])
Insulin
Item
insulin within 3 months of screening.
boolean
C0021641 (UMLS CUI [1])
Pramlintide
Item
pramlintide within 3 months of screening.
boolean
C0537551 (UMLS CUI [1])